Mutation-specific peptide vaccine against midline gliomas used in patients

A dendritic cell vaccine was safe and induced immune responses in patients with multiple myeloma

Combination of cancer vaccine and T cell therapy benefits patients with advanced ovarian cancer

Mutation-specific peptide vaccine against midline gliomas used in patients for the first time